BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
BTX.WS was delisted on the 26th of September, 2018.
38 hedge funds and large institutions have $131K invested in BioTime Inc Warrants (Expiring October 1, 2018) in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
15% more funds holding
Funds holding: 33 → 38 (+5)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
51% less capital invested
Capital invested by funds: $268K → $131K (-$137K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.38K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
+$1.85K |
| 3 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
+$53 |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$20 |
| 5 |
Morgan Stanley
New York
|
+$10 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$41.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$121 |
| 3 |
IA
IFP Advisors
Tampa,
Florida
|
-$45 |
| 4 |
Barclays
London,
United Kingdom
|
-$1 |
| 5 |
Wells Fargo
San Francisco,
California
|
-$1 |
BTX.WS Hedge Fund Activity: Q4 2017 in Review
38 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) for Q4 2017, worth a combined $131K — down 51% from $268K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new BTX.WS positions and 2 closed out — a net gain of 5 holders — while 3 added to existing stakes and 5 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $3.38K. The largest seller was Ionic Capital Management, cutting an estimated $41.2K.
- 38 institutional investors held BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) as of Q4 2017, up from 33 in Q3 2017.
- Funds reported $131K of BioTime Inc Warrants (Expiring October 1, 2018) stock for Q4 2017, down 51% quarter-over-quarter.
- 7 funds opened new BioTime Inc Warrants (Expiring October 1, 2018) positions in Q4 2017 and 2 closed out, a net change of +5 holders.
- The largest BioTime Inc Warrants (Expiring October 1, 2018) buyer in Q4 2017 was Susquehanna International Group, an estimated $3.38K added.
- The largest BioTime Inc Warrants (Expiring October 1, 2018) seller in Q4 2017 was Ionic Capital Management, an estimated $41.2K sold.
Based on aggregated 13F filings for Q4 2017.